Insulin degludec and liraglutide Subcutaneous and Methylphen Tablets
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Methylphen Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
Brand name: Hyophen, Prosed/DS, Urophen MB
Synonyms: Methenamine, Phenyl Salicylate, Methylene Blue, Benzoic Acid, Hyoscyamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate CD Capsules
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate Chewable Tablets
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate Controlled-Release Tablets
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate ER Capsules
- Insulin degludec and liraglutide Subcutaneous-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Methylphen Tablets-Insulin degludec Subcutaneous
- Methylphen Tablets-Insulin detemir
- Methylphen Tablets-Insulin Detemir (Cartridges and Prefilled Syringes)
- Methylphen Tablets-Insulin Detemir (Vials)
- Methylphen Tablets-Insulin detemir Subcutaneous
- Methylphen Tablets-Insulin glargine